Track the Inhibitor Therapeutics, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €14.5m. The latest transaction was disclosed on 24 June 2026 (Attribution). Among the most active insiders: Jerman Michael Allen. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.